KMI
38
2
LEN
22
8
COP
42
-3
VLO
50
-2
FITB
53
3
WY
20
-4
WBA
34
2
PEG
62
2
C
71
3
ZION
59
2
LNC
43
8
WFC
69
6
PNW
52
-3
CCI
28
3
JNJ
51
10
LMT
49
-6
MRK
45
4
AIZ
40
-16
LLY
60
6
CVX
32
3
KMI
38
2
LEN
22
8
COP
42
-3
VLO
50
-2
FITB
53
3
WY
20
-4
WBA
34
2
PEG
62
2
C
71
3
ZION
59
2
LNC
43
8
WFC
69
6
PNW
52
-3
CCI
28
3
JNJ
51
10
LMT
49
-6
MRK
45
4
AIZ
40
-16
LLY
60
6
CVX
32
3
Financhill
Back

Legend Biotech Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
43

LEGN
Legend Biotech

Last Price:
$34.89
Seasonality Move:
2.5%

7 Day Trial

ALL ACCESS PASS

$ 7

How to hack a $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa

Legend Biotech Stock Forecast

  • Over the next 52 weeks, Legend Biotech has on average historically risen by 3.5% based on the past 5 years of stock performance.
  • Legend Biotech has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Legend Biotech Stock Undervalued?
    The current Legend Biotech [LEGN] share price is $34.89. The Score for LEGN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • LEGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Legend Biotech Stock Go Up Next Year?

  • Over the next 52 weeks, Legend Biotech has on average historically risen by 3.5% based on the past 5 years of stock performance.

Legend Biotech Stock Rating

Sell
43
Legend Biotech (LEGN) is a Sell

Is Legend Biotech overpriced?

  • Legend Biotech has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Legend Biotech Stock Price History

Is LEGN stock going to rise?

  • The current trend is moderately bullish and LEGN is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
legendbiotech.com

52-Week Data

52-Week High:
60.87
52-Week Low:
27.34

Prediction Charts

Market Cap:
6.4B
Price in USD:
34.89
Volume:
884.5K
Beta:
0.13

Technical Analysis

SMA50:
32.20
SMA100:
34.14
SMA200:
38.43
52-Wk Change:
-13.81%

Stock Predictions

  • Is Legend Biotech stock public?
    Yes, Legend Biotech is a publicly traded company.
  • What is the Legend Biotech stock quote today?
    The Legend Biotech stock price is 34.89 USD today.
  • How to buy Legend Biotech stock online?
    You can buy Legend Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-30 28.90 28.95 29.07 27.98
Jun-2 28.94 29.32 29.79 28.61
Jun-3 29.50 28.43 29.61 28.16
Jun-4 28.90 30.36 32.45 28.78
Jun-5 31.62 31.48 32.18 30.70
Jun-6 32.32 35.00 35.20 32.14
Jun-9 36.66 34.78 36.72 34.26
Jun-10 34.99 37.64 38.00 34.99
Jun-11 37.31 36.59 37.90 36.05
Jun-12 36.66 37.91 39.36 36.66
Jun-13 36.86 36.83 37.19 36.32
Jun-16 36.51 35.84 36.71 35.26
Jun-17 34.39 34.70 35.08 33.84
Jun-18 34.80 34.89 35.29 34.51

Legend Biotech Earnings

Legend Biotech Earnings Report: Per Share Legend Biotech Earnings Q1 Q2 Q3 and Q4 last year and next year.

Legend Biotech Forecast Revenue Growth

Legend Biotech Stock Analysis: Historical quarterly revenues per share for Legend Biotech and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.18 per share, an increase this year of $0.60 per share, and an increase next year of $1.39 per share.

* Legend Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.